Prediction of Treatment Response in Head and Neck Cancer by Magnetic Resonance Spectroscopy

References

1. ↵
   American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society
2. ↵
   Chisholm GD, Hedlund PO, Adolfsson J, et al. The TNM system of 1992: Comments from the TNM working group. Scand J Urol Nephrol Suppl 1994;162:107–114

   PubMed
3. ↵
   Wennerberg J. Predicting response to therapy of squamous cell carcinoma of the head and neck [review]. Anticancer Res 1996;16:2389–2396

   PubMed
4. ↵
   Kurek R, Kalogera-Fountzila A, Muskalla K, Domingo Cebollada J, Diaz Gonzalez FJ. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292–297

   CrossRefPubMed
5. ↵
   Rubio Bueno P, Naval Gias L, Garcia Delgado R, et al. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 1998;20:232–239

   CrossRefPubMed
6. ↵
   Syms CA 3rd, Eibling DE, McCoy JP Jr, et al. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 1995;105:149–155

   PubMed
7. ↵
   Raybaud-Diogene H, Tetu B, Morency R, Fortin A, Monteil RA. p53 overexpression in head and neck squamous cell carcinoma. Eur J Cancer B Oral Oncol 1996;32:143–149

   CrossRef
8. Shimaya K, Shiozaki H, Inoue M, et al. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1993;422:271–276

   CrossRefPubMed
9. ↵
   Field JK, Malliri A, Butt SA. p53 overexpression in end stage squamous cell carcinoma of the head and neck: correlates with a very poor clinical outcome. Int J Oncol 1993;3:431–435
10. ↵
    Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992;52:178–182

    CrossRefPubMedWeb of Science
11. ↵
    Frank JL, Bur ME, Garb JL, et al. p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer 1994;73:181–186

    CrossRefPubMedWeb of Science
12. ↵
    Anneroth G, Batsakis J, Luna M. Review of the literature and recommended system of malignant grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95:229–249

    PubMedWeb of Science
13. ↵
    Bezabeh T, Smith ICP, Krupnik E, et al. Diagnostic potential for cancer via ¹H magnetic resonance spectroscopy of colon tissue. Anticancer Res 1996;16:1553–1558

    PubMed
14. Bezabeh T, El-Sayed S, Patel R, et al. Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility. Sarcoma 2002;6:97–103
15. ↵
    Hahn P, Smith ICP, Leboldus L, Littman C, Somorjai RL, Bezabeh T. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. Cancer Res 1997;57:3398–3401

    Abstract/FREE Full Text
16. Wallace JC, Raaphorst GP, Somorjai RL, et al. Classification of ¹H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn Reson Med 1997;38:569–576

    PubMed
17. ↵
    Somorjai RL, Nikulin AE, Pizzi N, et al. Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms. Magn Reson Med 1995;33:257–263

    PubMedWeb of Science
18. ↵
    Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001;88:1234–1240

    CrossRefPubMedWeb of Science
19. ↵
    Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 1997;18:1057–1072

    Abstract
20. ↵
    Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol 1996;17:1485–1490

    Abstract
21. El-Sayed S, Bezabeh T, Odlum O, et al. An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region. Head Neck 2002;24:766–772

    CrossRefPubMed
22. Shah GV, Fischbein NJ, Patel R, Mukherji SK. Newer MR imaging techniques for head and neck. Magn Reson Imaging Clin N Am 2003;11:449–469

    CrossRefPubMed
23. Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1930–1935

    Abstract/FREE Full Text
24. Gerstle RJ, Aylward SR, Kromhout-Schiro S, Mukherji SK. The role of neural networks in improving the accuracy of MR spectroscopy for the diagnosis of head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2000;21:1133–1138

    Abstract/FREE Full Text
25. ↵
    King AD, Yeung DK, Ahuja AT, et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol 2004;25:484–490

    Abstract/FREE Full Text
26. ↵
    Shukla-Dave A, Poptani H, Loevner LA, et al. Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Acad Radiol 2002;9:688–694

    CrossRefPubMed
27. ↵
    Kuesel AC, Kroft T, Saunders JK, et al. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. Magn Reson Med 1992;27:349–355

    PubMed
28. ↵
    Griffiths JR, Tate AR, Howe FA, Stubbs M; Group on MRS Application to Cancer. Magnetic resonance spectroscopy of cancer-practicalities of multi-centre trials and early results in non-Hodgkin’s lymphoma. Eur J Cancer 2002;38:2085–2093
29. ↵
    Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303–324

    PubMedWeb of Science
30. ↵
    Leach MO. Introduction to in vivo MRS of cancer: new perspectives and open problems. Anticancer Res 1996;16:1503–1514

    PubMedWeb of Science
31. ↵
    Degani H, Ronen SM, Furman-Haran E. Breast cancer: spectroscopy and imaging of cells and tumors. In: Gillies RJ, ed. NMR in physiology and biomedicine. San Diego: Academic Press;1994;329–352
32. ↵
    Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80–84

    Abstract/FREE Full Text
33. ↵
    Bhujwalla ZM, Aboagye EO, Gillies RJ, Chacko VP, Mendola CE, Backer JM. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a ³¹P nuclear magnetic resonance study in vivo and vitro. Magn Reson Med 1999;41:897–903

    CrossRefPubMedWeb of Science
34. ↵
    Bezabeh T, El-Sayed S, Odlum O, et al. Grading of head and neck tumors by ¹H MRS: an approach with potential clinical utility. Proc Int Soc Magn Reson Abst 2001;9:2348 [abstract]
35. ↵
    Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516–524

    PubMedWeb of Science
36. ↵
    Wald LL, Nelson SJ, Day MR, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;87:525–534

    PubMedWeb of Science
37. ↵
    Menard C, Smith ICP, Somorjai RL, et al. Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity. Int J Radiat Oncol Biol Phys 2001;50:317–323

    CrossRefPubMed
38. ↵
    Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661–666

    PubMedWeb of Science
39. ↵
    Tarnawski R, Sokol M, Pieniazek P, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271–1276

    CrossRefPubMedWeb of Science
40. ↵
    Brizel DM, Schroeder T, Scher RL, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:349–353

    PubMedWeb of Science
41. ↵
    Okada A, Takehara H, Yoshida K, et al. Increased aspartate and glutamate levels in both gastric and colon cancer tissues. Tokushima J Exp Med 1993;40:19–25

    PubMed
42. ↵
    Bezabeh T, Somorjai RL, Smith ICP, et al. The use of ¹H magnetic resonance spectroscopy in the study of inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn’s disease. Am J Gastroenterol 2001;96:442–48

    CrossRefPubMedWeb of Science
43. ↵
    Huang W, Roche P, Shindo M, et al. Evaluation of head and neck tumor response to therapy using in vivo ¹H MR spectroscopy: correlation with pathology. Proc Int Soc Magn Reson Abst 2000;8:552 [abstract]